Doraiswamy Vinayak
Officer at ATRC
- Sold, on record
- $1.6M
- Dollars the filings state
- Form 4 sales
- 7
- Latest Jul 28, 2026
- Form 144 notices
- 5
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- ATRCAtriCure, Inc.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice ATRCNoticeAug 5, 2025 2025
Filed to sell 2,500 shares ($91k)
Doraiswamy Vinayak, Officer
No 10b5-1 planFiling
- 2 Form 4 sale ATRCNo planAug 5, 2025 same day
Sold 2,500 shares at $36.58 ($91k)
Doraiswamy Vinayak, Chief Scientific Officer
No 10b5-1 planSold 3.4% of holdings ($2.7M position)71,872 shares leftFollows a Form 144Filing
- 3 Form 144 notice ATRCNoticeMar 12, 2026 +219 days
Filed to sell 5,000 shares ($149k)
Doraiswamy Vinayak, Officer
No 10b5-1 planFiling
- 4 Form 4 sale ATRCNo planMar 12, 2026 same day
Sold 5,000 shares at $29.83 ($149k)
Doraiswamy Vinayak, Chief Scientific Officer
No 10b5-1 planSold 4.9% of holdings ($3M position)96,875 shares leftFollows a Form 144Filing
- 5 Form 144 notice ATRCNoticeMay 15, 2026 +64 days
Filed to sell 5,000 shares ($141k)
Doraiswamy Vinayak, Officer
No 10b5-1 plan2x usual sizeFiling
- 6 Form 4 sale ATRCNo planMay 15, 2026 same day
Sold 5,000 shares at $28.13 ($141k)
Doraiswamy Vinayak, Chief Scientific Officer
No 10b5-1 planSold 5.2% of holdings ($2.7M position)91,875 shares left2x usual sizeFollows a Form 144Filing
- 7 Form 144 notice ATRCNoticeJul 28, 2026 +74 days
Filed to sell 6,000 shares ($233k)
Doraiswamy Vinayak, Officer
No 10b5-1 plan1.6x usual sizeFiling
- 8 Form 4 sale ATRCNo planJul 28, 2026 same day
Sold 6,000 shares at $38.88 ($233k)
Doraiswamy Vinayak, Chief Scientific Officer
No 10b5-1 planSold 6.5% of holdings ($3.6M position)86,511 shares left1.6x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (12)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jul 28, 2026 | Jul 30, 2026 | ATRC | Chief Scientific Officer | Form 4 sale | 6,000 | $233k | 6.5% | No plan | SEC |
| Jul 28, 2026 | Jul 28, 2026 | ATRC | Officer | Form 144 notice | 6,000 | $233k | Notice | SEC | |
| May 15, 2026 | May 18, 2026 | ATRC | Chief Scientific Officer | Form 4 sale | 5,000 | $141k | 5.2% | No plan | SEC |
| May 15, 2026 | May 15, 2026 | ATRC | Officer | Form 144 notice | 5,000 | $141k | Notice | SEC | |
| Mar 12, 2026 | Mar 16, 2026 | ATRC | Chief Scientific Officer | Form 4 sale | 5,000 | $149k | 4.9% | No plan | SEC |
| Mar 12, 2026 | Mar 12, 2026 | ATRC | Officer | Form 144 notice | 5,000 | $149k | Notice | SEC | |
| Aug 5, 2025 | Aug 7, 2025 | ATRC | Chief Scientific Officer | Form 4 sale | 2,500 | $91k | 3.4% | No plan | SEC |
| Aug 5, 2025 | Aug 5, 2025 | ATRC | Officer | Form 144 notice | 2,500 | $91k | Notice | SEC | |
| May 28, 2025 | May 30, 2025 | ATRC | Chief Scientific Officer | Form 4 sale | 2,500 | $84k | 3.3% | No plan | SEC |
| May 28, 2025 | May 28, 2025 | ATRC | Officer | Form 144 notice | 2,500 | $84k | Notice | SEC | |
| Sep 15, 2022 | Sep 19, 2022 | ATRC | Chief Scientific Officer | Form 4 sale | 4,983 | $229k | 20.4% | Plan not stated | SEC |
| Jul 12, 2021 | Jul 14, 2021 | ATRC | Chief Scientific Officer | Form 4 sale | 7,672 | $638k | 31.3% | Unusual | SEC |